Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma.

Suzuki S, Kofune H, Uozumi K, Yoshimitsu M, Arima N, Ishitsuka K, Ueno SI, Kosai KI.

BMC Cancer. 2019 May 29;19(1):516. doi: 10.1186/s12885-019-5730-1.

2.

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.

Mori H, Kubo M, Kai M, Yamada M, Kurata K, Kawaji H, Kaneshiro K, Osako T, Nishimura R, Arima N, Okido M, Kishimoto J, Oda Y, Nakamura M.

Breast Cancer Res Treat. 2019 May 8. doi: 10.1007/s10549-019-05256-2. [Epub ahead of print]

PMID:
31069590
3.

Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors.

Arima N, Nishimura R, Osako T, Okumura Y, Nakano M, Fujisue M, Nishiyama Y, Toyozumi Y.

Oncol Lett. 2019 Jan;17(1):616-622. doi: 10.3892/ol.2018.9633. Epub 2018 Oct 29.

4.

A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide.

Kishimoto W, Takiuchi Y, Nakae Y, Tabata S, Fukunaga A, Matsuzaki N, Yuba Y, Kitano T, Arima N.

Int J Hematol. 2019 Apr;109(4):499-504. doi: 10.1007/s12185-018-02587-6. Epub 2019 Jan 2.

PMID:
30604313
5.

Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.

Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y.

PLoS One. 2018 Aug 24;13(8):e0203084. doi: 10.1371/journal.pone.0203084. eCollection 2018.

6.

In vitro effects of arsenic trioxide, interferon α and zidovudine in adult T cell leukemia/lymphoma cells.

Hachiman M, Yoshimitsu M, Ezinne C, Kuroki A, Kozako T, Arima N.

Oncol Lett. 2018 Jul;16(1):1305-1311. doi: 10.3892/ol.2018.8771. Epub 2018 May 22.

7.

Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study.

Matsuda A, Kawabata H, Tohyama K, Maeda T, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Usuki K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Ohta A, Miyazaki Y, Nakao S, Ozawa K, Arai S, Kurokawa M, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Leuk Res. 2018 Nov;74:137-143. doi: 10.1016/j.leukres.2018.06.003. Epub 2018 Jun 7.

PMID:
29914726
8.

[Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].

Nakamura D, Hayashida M, Kubota K, Matsuura E, Tabuchi T, Arima N, Inoue H, Yoshimitsu M, Ishitsuka K.

Rinsho Ketsueki. 2018;59(5):489-491. doi: 10.11406/rinketsu.59.489. Japanese.

PMID:
29877235
9.

Development of sugar chain-binding single-chain variable fragment antibody to adult T-cell leukemia cells using glyco-nanotechnology and phage display method.

Muchima K, Todaka T, Shinchi H, Sato A, Tazoe A, Aramaki R, Kakitsubata Y, Yokoyama R, Arima N, Baba M, Wakao M, Ito Y, Suda Y.

J Biochem. 2018 Apr 1;163(4):281-291. doi: 10.1093/jb/mvy005.

PMID:
29351623
10.

Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.

Nishikawa H, Taniguchi Y, Matsumoto T, Arima N, Masaki M, Shimamura Y, Inoue K, Horino T, Fujimoto S, Ohko K, Komatsu T, Udaka K, Sano S, Terada Y.

Kidney Int. 2018 Mar;93(3):599-614. doi: 10.1016/j.kint.2017.09.017. Epub 2017 Dec 11.

PMID:
29241623
11.

Usefulness of virtual touch quantification for staging liver fibrosis in patients with hepatitis C, and factors affecting liver stiffness measurement failure compared with liver biopsy.

Tsukano N, Miyase S, Saeki T, Mizobe K, Iwashita H, Arima N, Fujiyama S.

Hepatol Res. 2018 Apr;48(5):373-382. doi: 10.1111/hepr.13041. Epub 2018 Jan 15.

PMID:
29226524
12.

Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Apr;24(4):717-725. doi: 10.1016/j.bbmt.2017.11.029. Epub 2017 Dec 27.

13.

Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.

Baba M, Toyama M, Sakakibara N, Okamoto M, Arima N, Saijo M.

Antivir Chem Chemother. 2017 Dec;25(3):83-89. doi: 10.1177/2040206617740303. Epub 2017 Nov 3.

14.

Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.

Nakae Y, Hyuga M, Terada Y, Kishimoto W, Fukunaga A, Tabata S, Maesako Y, Komatsu K, Higuchi O, Nakane T, Arima N.

Intern Med. 2017 Dec 15;56(24):3347-3351. doi: 10.2169/internalmedicine.9096-17. Epub 2017 Oct 11.

15.

Lifting of evacuation orders and subsequent efforts in Japan.

Arima N.

Ann ICRP. 2016 Dec;45(2_suppl):41-47. doi: 10.1177/0146645316680577. Epub 2016 Dec 19.

PMID:
28952349
16.

Elimination of Plasma Cytokines Markedly Improves Non-Septic Multiple Organ Dysfunction Syndrome in Human Immunodeficiency Virus-Associated Hodgkin Lymphoma.

Fujiwara M, Yanagida S, Kakita H, Arima N.

Ther Apher Dial. 2017 Dec;21(6):640-641. doi: 10.1111/1744-9987.12574. Epub 2017 Jul 17. No abstract available.

PMID:
28714149
17.

Distribution of six anticancer drugs and a variety of other pharmaceuticals, and their sorption onto sediments, in an urban Japanese river.

Azuma T, Arima N, Tsukada A, Hirami S, Matsuoka R, Moriwake R, Ishiuchi H, Inoyama T, Teranishi Y, Yamaoka M, Ishida M, Hisamatsu K, Yunoki A, Mino Y.

Environ Sci Pollut Res Int. 2017 Aug;24(23):19021-19030. doi: 10.1007/s11356-017-9525-0. Epub 2017 Jun 28.

PMID:
28660504
18.

Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry.

Kawabata H, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Zaike Y, Usuki K, Chiba S, Ishikawa T, Arima N, Nogawa M, Ohta A, Miyazaki Y, Mitani K, Ozawa K, Arai S, Kurokawa M, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Int J Hematol. 2017 Sep;106(3):375-384. doi: 10.1007/s12185-017-2250-0. Epub 2017 May 11.

PMID:
28497239
19.

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.

Nishimura R, Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K.

Oncology. 2017;93(1):51-61. doi: 10.1159/000468521. Epub 2017 May 6.

PMID:
28478451
20.

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence.

Shien T, Tanaka T, Tanabe M, Okumura Y, Masuda N, Yoshida A, Arima N, Komoike Y, Tanaka S, Iwase T, Taguchi T, Nakatsukasa K, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Oncol Lett. 2017 Mar;13(3):1071-1077. doi: 10.3892/ol.2016.5538. Epub 2016 Dec 27.

21.

Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation.

Tanaka S, Imataki O, Kitaoka A, Fujioka S, Hanabusa E, Ohbayashi Y, Uemura M, Arima N, Yamamoto T.

J Cancer Res Clin Oncol. 2017 Jun;143(6):1083-1092. doi: 10.1007/s00432-016-2336-8. Epub 2017 Feb 21.

PMID:
28224299
22.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Mori H, Kubo M, Yamaguchi R, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Oda Y, Nakamura M.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

23.

Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.

Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N.

Leukemia. 2017 Jan;31(1):268. doi: 10.1038/leu.2016.188. No abstract available.

PMID:
28050024
24.

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.

Mori H, Kubo M, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Miyazaki T, Oda Y, Otsuka T, Nakamura M.

PLoS One. 2016 Dec 15;11(12):e0167016. doi: 10.1371/journal.pone.0167016. eCollection 2016.

25.

The mevalonate pathway regulates primitive streak formation via protein farnesylation.

Okamoto-Uchida Y, Yu R, Miyamura N, Arima N, Ishigami-Yuasa M, Kagechika H, Yoshida S, Hosoya T, Nawa M, Kasama T, Asaoka Y, Alois RW, Elling U, Penninger JM, Nishina S, Azuma N, Nishina H.

Sci Rep. 2016 Nov 24;6:37697. doi: 10.1038/srep37697.

26.

Systemic delivery of small interfering RNA targeting nuclear factor κB in mice with collagen-induced arthritis using arginine-histidine-cysteine based oligopeptide-modified polymer nanomicelles.

Kanazawa T, Endo T, Arima N, Ibaraki H, Takashima Y, Seta Y.

Int J Pharm. 2016 Dec 30;515(1-2):315-323. doi: 10.1016/j.ijpharm.2016.10.033. Epub 2016 Oct 17.

PMID:
27765724
27.

Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells.

Kozako T, Soeda S, Yoshimitsu M, Arima N, Kuroki A, Hirata S, Tanaka H, Imakyure O, Tone N, Honda S, Soeda S.

FEBS Open Bio. 2016 Apr 13;6(5):442-60. doi: 10.1002/2211-5463.12055. eCollection 2016 May.

28.

Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.

Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N.

Leukemia. 2017 Jan;31(1):203-212. doi: 10.1038/leu.2016.174. Epub 2016 Jun 14. Erratum in: Leukemia. 2017 Jan;31(1):268. Ishiyama, K-I [corrected to Ishiyama, K].

PMID:
27349810
29.
30.

[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].

Okumura Y, Oae M, Shiraishi Y, Soda T, Kanamaru H, Arima N.

Hinyokika Kiyo. 2016 May;62(5):271-4. Japanese.

31.

Detection of rapidly progressing hepatic angiosarcoma on autopsy that would have definitely been diagnosable on percutaneous liver biopsy.

Saito H, Goto T, Inamura K, Iwasaki N, Yamabe S, Tada S, Urata J, Toyozumi Y, Arima N.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):837-40. doi: 10.11405/nisshoshi.113.837. Japanese. No abstract available.

PMID:
27151481
32.

Local recurrence risk after previous salvage mastectomy.

Tanabe M, Iwase T, Okumura Y, Yoshida A, Masuda N, Nakatsukasa K, Shien T, Tanaka S, Komoike Y, Taguchi T, Arima N, Nishimura R, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26.

PMID:
27055945
33.

ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation.

Nishioka T, Arima N, Kano K, Hama K, Itai E, Yukiura H, Kise R, Inoue A, Kim SH, Solnica-Krezel L, Moolenaar WH, Chun J, Aoki J.

Sci Rep. 2016 Mar 23;6:23433. doi: 10.1038/srep23433.

34.

[Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].

Hirano T, Tsuji T, Yamasaki H, Toyozumi Y, Arima N, Tsuda H.

Rinsho Ketsueki. 2016 Feb;57(2):171-4. doi: 10.11406/rinketsu.57.171. Japanese.

PMID:
26935635
35.

Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.

Miyasaka N, Miura O, Kawaguchi T, Arima N, Morishita E, Usuki K, Morita Y, Nishiwaki K, Ninomiya H, Gotoh A, Imashuku S, Urabe A, Shichishima T, Nishimura J, Kanakura Y.

Int J Hematol. 2016 Jun;103(6):703-12. doi: 10.1007/s12185-016-1946-x. Epub 2016 Feb 8. Review.

PMID:
26857155
36.

Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.

Yoshida A, Takahashi O, Okumura Y, Arima N, Nakatsukasa K, Tanabe M, Shien T, Masuda N, Tanaka S, Komoike Y, Taguchi T, Iwase T, Nishimura R, Inaji H, Yamauchi H, Ishitobi M; Collaborative Study Group of Scientific Research of Japanese Breast Cancer Society.

Eur J Surg Oncol. 2016 Apr;42(4):474-80. doi: 10.1016/j.ejso.2016.01.011. Epub 2016 Jan 22.

PMID:
26853760
37.

Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents.

Azuma T, Arima N, Tsukada A, Hirami S, Matsuoka R, Moriwake R, Ishiuchi H, Inoyama T, Teranishi Y, Yamaoka M, Mino Y, Hayashi T, Fujita Y, Masada M.

Sci Total Environ. 2016 Apr 1;548-549:189-197. doi: 10.1016/j.scitotenv.2015.12.157. Epub 2016 Jan 21.

PMID:
26802347
38.

A Modified Murine Embryonic Stem Cell Test for Evaluating the Teratogenic Effects of Drugs on Early Embryogenesis.

Yu R, Miyamura N, Okamoto-Uchida Y, Arima N, Ishigami-Yuasa M, Kagechika H, Nishina H.

PLoS One. 2015 Dec 18;10(12):e0145286. doi: 10.1371/journal.pone.0145286. eCollection 2015.

39.

Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations.

Okabe M, Yamaguchi H, Usuki K, Kobayashi Y, Kawata E, Kuroda J, Kimura S, Tajika K, Gomi S, Arima N, Mori S, Ito S, Koizumi M, Ito Y, Wakita S, Arai K, Kitano T, Kosaka F, Dan K, Inokuchi K.

Leuk Res. 2016 Jan;40:68-76. doi: 10.1016/j.leukres.2015.11.002. Epub 2015 Nov 10.

PMID:
26614694
40.

A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

Oncology. 2016;90(1):43-50. doi: 10.1159/000441525. Epub 2015 Nov 28.

PMID:
26613521
41.

Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.

Arima N, Nakamura F, Yabe T, Tanaka J, Fuji S, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Mori T, Kobayashi N, Hoshino T, Kato C, Kanamori H, Nakamae H, Atsuta Y, Morishima Y, Kanda Y.

Biol Blood Marrow Transplant. 2016 Mar;22(3):423-31. doi: 10.1016/j.bbmt.2015.09.029. Epub 2015 Oct 9.

42.

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index.

Arima N, Nishimura R, Osako T, Nishiyama Y, Fujisue M, Okumura Y, Nakano M, Tashima R, Toyozumi Y.

J Clin Pathol. 2016 Mar;69(3):255-9. doi: 10.1136/jclinpath-2015-203174. Epub 2015 Sep 29.

43.

Manoalide-related Sesterterpene from the Marine Sponge Luffariella variabilis.

Hamada T, Harada D, Hirata M, Yamashita K, Palaniveloo K, Okamura H, Iwagawa T, Arima N, Iriguchi T, de Voogd NJ, Vairappan CS.

Nat Prod Commun. 2015 Jun;10(6):863-4.

PMID:
26197501
44.

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.

Tashima R, Nishimura R, Osako T, Nishiyama Y, Okumura Y, Nakano M, Fujisue M, Toyozumi Y, Arima N.

PLoS One. 2015 Jul 15;10(7):e0119565. doi: 10.1371/journal.pone.0119565. eCollection 2015.

45.

A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.

Nakamura D, Yoshimitsu M, Kuroki A, Hachiman M, Kamada Y, Ezinne CC, Arai A, Inoue H, Hamada H, Hayashida M, Suzuki S, Fujino S, Arima N, Arima M, Tabuchi T, Okada S, Arima N.

Exp Hematol. 2015 Nov;43(11):944-50. doi: 10.1016/j.exphem.2015.06.303. Epub 2015 Jul 11.

PMID:
26169955
46.

Survival time according to the year of recurrence and subtype in recurrent breast cancer.

Nakano M, Fujisue M, Tashima R, Okumura Y, Nishiyama Y, Ohsako T, Toyozumi Y, Arima N, Nishimura R.

Breast. 2015 Oct;24(5):588-93. doi: 10.1016/j.breast.2015.06.003. Epub 2015 Jun 20.

PMID:
26099804
47.

Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells.

Kozako T, Suzuki T, Yoshimitsu M, Uchida Y, Kuroki A, Aikawa A, Honda S, Arima N, Soeda S.

Sci Rep. 2015 Jun 19;5:11345. doi: 10.1038/srep11345.

48.

Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.

Masamoto I, Yoshimitsu M, Kuroki A, Horai S, Ezinne CC, Kozako T, Hachiman M, Kamada Y, Baba M, Arima N.

Leuk Lymphoma. 2016;57(3):685-91. doi: 10.3109/10428194.2015.1063140. Epub 2015 Jul 25.

PMID:
26077361
49.

Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Osako T, Nishimura R, Nishiyama Y, Okumura Y, Tashima R, Nakano M, Fujisue M, Toyozumi Y, Arima N.

Int J Clin Oncol. 2015 Dec;20(6):1093-101. doi: 10.1007/s10147-015-0827-2. Epub 2015 Apr 9.

PMID:
25855313
50.

Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.

Okumura Y, Nishimura R, Nakatsukasa K, Yoshida A, Masuda N, Tanabe M, Shien T, Tanaka S, Arima N, Komoike Y, Taguchi T, Iwase T, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Eur J Surg Oncol. 2015 Apr;41(4):548-52. doi: 10.1016/j.ejso.2015.01.030. Epub 2015 Feb 7.

PMID:
25682910

Supplemental Content

Support Center